Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Redefining Tetanus Disease Market Analysis with DLI's Epidemiology Study, Drug Insights, Clinical Trial Management, and Regulatory Consulting Services | Disease Landscape Insights

This image opens in the lightbox

News provided by

Disease Landscape Insights

11 Oct, 2023, 14:40 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Oct. 11, 2023 /PRNewswire/ -- Tetanus Disease is a bacterial infection that can be fatal if not treated in time. It is caused by a bacterium called clostridium tetani. According to a Tetanus statistics released by a reliable source, nearly 38,000 people lost their lives from this disease in the year 2017. Administration of Tetanus vaccine is the best way to prevent its occurrence.

Tetanus is severe infection triggered by clostridium tetani, a bacterium that dwells in animal faeces, soil, and dust. This microorganism is known to produce a toxin known as tetanospasmin which can interfere with nerve signals in the body and cause muscle spasms and stiffness. The bacteria can enter body via wounds, cuts, or puncture injuries, especially if the wound is contaminated with dirt or debris. Apart from human beings, tetanus in livestock and some other animals is also a matter of concern.

Disease Landscape Insights health consultant has been playing an indispensable role in assisting Tetanus Disease Market players in researching diseases and developing comprehensive strategies for diagnosis, treatment, and tetanus prevention.  It has been empowering them with disease insights, regulatory guidelines information, and overall market intelligence.  It has been supporting them in treatment gaps identification, clinical trial assessment, clinical trial feasibility analysis, along with price and market access-based activities.

Price and Market Access

By procuring DLI's healthcare consulting services, researchers, clinicians, and pharmaceutical companies are being able to efficiently conduct commercial strategy analysis, product portfolio analysis, product portfolio extension-based activities while being strengthened with product launch services, product development services, drug development assistance, post launch services, and regulatory consulting services, among others. By offering a holistic view of the disease landscape, it is enabling healthcare stakeholders to make informed decisions, allocate resources efficiently, and ultimately contribute to improving patient outcomes and public health.

Causes And Symptoms Of This Disease:

Tetanus is a fatal ailment which has claimed millions of lives over the years. The major factors leading to the onset of this ailment are wound contamination, prolonged exposure to oxygen deprived environments, incomplete vaccination, and exposure to tetani spores. Wounds are advised to be cleaned and covered in order to prevent tetanus infection.

Talking about tetanus and pregnancy, expecting mothers are highly vulnerable to this severe infection. They are advised to practice good hygiene and wound care to minimize the risk of tetanus and other infections. This includes cleaning and disinfecting any wounds, as well as avoiding contact with soil or materials that may be contaminated with C. tetani spores.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @

https://www.diseaselandscape.com/downloadsample/postid/13

The primary symptoms of this disease are difficulty swallowing, fever, rapid heart rate, muscle spasms, breathing issues, and irritability.

Tetanus Diagnosis and Treatment:

This disease is diagnosed through the assessment of clinical symptoms like muscle stiffness, muscle spasms, especially in the jaw and neck (lockjaw), and other neurological symptoms. Apart from that, physicians also investigate the patient's medical history which comprises of information about recent injuries, wounds, or potential exposure to C. tetani spores.

Tetanus treatment constitutes of multiple approaches. A wide range of medications are prescribed in this condition. On such drug is the tetanus immune globulin which has the ability to neutralize the toxin that has already been produced by the bacteria. Alongside, muscle relaxants, antibiotics, proper wound care, and timely vaccines are also pivotal when it comes to the treatment and management of this disease.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @

https://www.diseaselandscape.com/checkout?report_id=13

Summing up:

Tetanus is a serious disease caused by the bacterium Clostridium tetani, commonly found in soil and dust. It enters the body through wounds, producing a potent neurotoxin. This toxin leads to muscle stiffness, spasms, and can be life-threatening. A pharma consulting services provider like DLI, can play a vital role in redefining tetanus disease management by conducting epidemiology studies, providing drug insights, managing clinical trials, and offering regulatory consulting services. Such services are essential in advancing the understanding of tetanus and improving its prevention and treatment.

Browse Through More Infectious Diseases Research Reports.

Related Report:

Case study on the development of novel medications.

Case Study: Software Application for Personalized Care with Data-Driven Insights.

Case Study: Cancer Vaccine Targeting an Antigen.

Case Study: Lung Cancer Immunotherapy Combination Trials.

software implementation for inventory and supply chain management.

Asset scouting for cystic fibrosis.

The Successful Commercialization of a Revolutionary Non-Invasive Glucose Monitoring Device after Regulatory Approval.

Investing in pancreatic cancer chemotherapy drugs.

Solid Tumor Diseases: A Comprehensive Guide to Detection and Therapeutic Strategies

Demodex Blepharitis: Diagnosis, Treatment, and Prevention

Duchenne Muscular Dystrophy (DMD): A Comprehensive Guide for Patients and Families

Hemophilia Disease Explained: Causes, Symptoms, and Treatment Options

Spinal Muscular Atrophy (SMA) Disease Chronicles: Navigating Life with Spinal Muscular Atrophy

Predictive analytics powered by AI: Unlocking Insights for the Future of Healthcare.

Natural Language Processing (NLP) in Healthcare: Unlocking the Potential.

Posluma: A Targeted Oncology Cutting-Edge Advancement in Prostate Cancer Imaging.

Fezolinetant by Veozah: Advancing Women's Health by Astellas Pharma Inc.

A Glimmer of Hope for Migraine Sufferers: Zavzpret.

Rethinking Treatment Options for a Better Future with Hemophilia Gene Therapy.

Reach New Heights with Mass Production of Benzathine Penicillin G as We Overcome the Challenge.

About Disease Landscape:  

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  

Contact Us:  

Disease Landscape Insights LLP  
6th Floor, Sr No.207, Office A H 6070 Phase 1  
Solitaire Business Hub, Viman Nagar  
Pune, Maharashtra, 411014.
Sales Contact: +44-2038074155  
Asia Office Contact: +917447409162 
Email: ajay@diseaselandscape.com    
Email: vishal@diseaselandscape.com
Blog: https://www.diseaselandscape.com/blogs
Case Study: https://www.diseaselandscape.com/casestudies    
Pharma consulting Services  

Follow Us: LinkedIn | Twitter | Facebook

Logo: https://mma.prnewswire.com/media/2217060/Disease_Landscape_Insights_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.